You just read:

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

News provided by

Regeneron Pharmaceuticals, Inc.

Jul 24, 2015, 07:15 ET